Survey for Specialty Pharmacies 2019

1. What is your title? *This question is required.

• CEO
• Vice President of Operations
• General Manager
• Director of Pharmacy
• Pharmacist in Charge
• Other - Write In Please enter an 'other' value for this selection.

2. How long have you worked in specialty pharmacy? *This question is required.

• Less than 6 months
• 6 months to one year
• 1-2 years
• 2-5 years
• 5-10 years
• Over 10 years

3. What disease states do you service in your specialty pharmacy model? *This question is required.

• Gastroenterology
• Infectious Disease
• Rheumatology
• Dermatology
• Oncology/Hematology
• Neurology
• Pediatrics
• Respiratory
• Immunology
• Other - Write In Please enter an 'other' value for this selection.

4. Has your patient census grown in the last year?   *This question is required.

• Yes
• No

5. Which specialties are driving growth? *This question is required.

• Gastroenterology
• Infectious Disease
• Rheumatology
• Dermatology
• Oncology/Hematology
• Neurology
• Pediatrics
• Respiratory
• Immunology
• Other - Write In Please enter an 'other' value for this selection.

6. How is the low unemployment rate impacting your ability to hire the right people? *This question is required.

• No impact
• Some impact
• Great impact
• Crippling my ability to grow

7. What percent growth in full-time employees do you anticipate in 2019-2020? *This question is required.

• Minimal
• 5-10%
• 11-20%
• Over 20%

13. Do you have access to limited distribution drugs (LDDs)?  *This question is required.

• Yes
• No
• List of the LDDs you have access to Please enter an 'other' value for this selection.

14. Have you gained access to any new LLD products in 2018? If so,  which product(s)? *This question is required.

• Yes
• No
• LDD access gained this year Please enter an 'other' value for this selection.

16. Do you provide data for manufacturers? *This question is required.

• Yes
• No

17. If you answered yes to question 16, which data aggregator do you use? *This question is required.

• IMS
• Symphony
• Walters Kluwer
• Prometrics
• Liquid Hub
• Integrichain
• Value Centric
• We do not use a data aggregator
• Other - Write In Please enter an 'other' value for this selection.

18. What is the average time from the receipt of a referral until the product is shipped to the patient, in a situation where a prior authorization is required? *This question is required.

• 1 day
• 2-3 days
• 4-7 days
• 1-2 weeks
• 3+ weeks

23. What software does your specialty pharmacy use?  Please select all software for operations, clinical care, and billing.   *This question is required.

• ScriptMed
• CPR+/Caretend
• New Leaf
• QS1
• McKesson Enterprise
• Pioneer Rx
• Rx30
• CarePoint
• ScriptPro
• MicroMerchant
• Asembia
• Therigy
• Developed Own Software
• Other - Write In Please enter an 'other' value for this selection.

24. What have been the two biggest challenges to adding access to lives in 2018? Please check two. *This question is required.

• Not dual accredited
• Not sure which contracts to go after
• Payors will not respond
• We don’t have someone dedicated exclusively to this role in our company
• We are too small
• The process is too difficult
• Other - Write In Please enter an 'other' value for this selection.

26. How many new payor networks did you gain access to or contract with in 2018? *This question is required.

• 0
• 1
• 2
• 3
• 4
• 5-9
• 10+

27. What accreditation(s) do you currently hold? *This question is required.

• URAC
• ACHC
• Joint Commission
• CPPA
• The Compliance Team
• Other - Write In Please enter an 'other' value for this selection.

28. If you do not have dual accreditation, would you say it has negatively impacted your company in any way? *This question is required.

• Yes
• No

29. Have you changed the size of your sales team in 2018? *This question is required.

• Added sales team members
• Reduced sales team members
• Stayed the same

31. How successful would you say your sales team has been at winning referrals? *This question is required.

• Outstanding
• Good
• Average
• Below Average
• Poor
• Unacceptable

36. Please indicate if you have experienced any of the following practices in your interactions with PBMs that also own a specialty pharmacy; please provide specific examples:

 

 

• Patient Steering - Independent Specialty Pharmacy (ISP) routinely receives specialty scripts from Doctor A, and ISP processes payment of those scripts via PBM-1, then specialty pharmacy owned by PBM1 (“PBM1-SP) calls Doctor A or patient and says perhaps you should switch to PBM1-SP
• Leveraging the formulary - PBM1-SP tells manufacturer that if the manufacturer does not allow the SP of the PBM1-SP in the manufacturer’s network, then the PBM1-SP will make things “difficult” for the manufacturer on its formulary
• Requiring certain staffing, drug inventory and adjudication times that are not practical to the potential service area
• Violating the Any Willing Pharmacy (AWP) process and requirement
• Detailed audits performed by the PBM1-SP as a condition of network participation, effectively permitting a competitor to review and gain insight into your proprietary business processes
• PBM1-SP requiring, as a condition for network participation, having a brick and mortar facility within a specified mile radius of the geographical location being serviced when, in fact, the PBM1-SP’s own SP does not meet the same requirement

37. Do your current PBM contracts allow you to discuss options to make a patient’s drug therapies more affordable? *This question is required.

• Yes
• No
• Unsure

39. As a result of DIR fees, have you had to decline participation in any Medicare Part D networks? *This question is required.

• Yes
• No
• Other - Write In Please enter an 'other' value for this selection.

40. As a result of DIR fees, have you had to reduce staff and if so how many people have lost their jobs as a result? *This question is required.

• Yes
• No
• Number of lost jobs Please enter an 'other' value for this selection.